Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penney Cowan

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|April 9, 2016
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendationsAnn M Taylor, Kristine Phillips, Kushang V Patel, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|April 13, 2012
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain Medicine (Malden, Mass.)|November 30, 2018
International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid TaperingBeth D Darnall, David Juurlink, Robert D Kerns, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pain|April 9, 2016
Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendationsAnn M Taylor, Kristine Phillips, Kushang V Patel, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|April 13, 2012
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain Medicine (Malden, Mass.)|November 30, 2018
International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid TaperingBeth D Darnall, David Juurlink, Robert D Kerns, et al.
Pageof 5